We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Nelson's Distillery & School (NDAS) makes and sells craft gin from its 290-litre state-of-the-art establishment. It also educates interested folks from its 28 seat Gin school in the art of making quality craft gin. Former Chef and founder, Neil Harrison, set out to create the best craft Gin and to educate others in the process. The company has produced and sold over 100,000 bottles since its founding in 2019. It aspires to become a contender in the global gin market valued at $15 billion. NDAS asserts that it is one of a few craft gin companies to win the coveted 3-star Great British Taste award, plus 6 other awards over 2 years. The company has also signed four contracts with the Hilton & Clayton hotels, three in the UK and one in Asia. NDAS will use the investment to expand its business and establish Nelson’s Gin school in all major cities.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £317,868
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
Span Health is a digital care platform that aims to help people avoid lifestyle-induced diseases, symptoms, medication, and complications. The company has helped more than 10,000 people to live a better and longer life. Span Health's easy-to-use mobile application allows patients to chat with clinicians, order blood tests at home, book video consultations, and see results in the application itself. Moreover, in 2019, the company agreed on a National Health Service (NHS) pilot test for 100 patients in collaboration with the National Institute of Health Research in North West London. Span Health will use the investment to provide employees with blood tests to screen for health risk factors and recover from detected illness safely and sustainably, improve its platform data insights, prediction and machine learning to better structure the clinician's processes, and further reduce its operational costs.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £134,892
Pharmseal is a software company that aims to disrupt clinical trial management. The company claims that companies typically use multiple applications for managing clinical trials from one or more vendors. This increases cost and complexity. Pharmaseal asserts that its cloud Business-2-Business (B2B) platform, Engility, simplifies control by providing a single management portal. The platform allows information to be centralised and accessed from a single platform. Pharmaseal claims that Engility will allow companies to save cost and time and enable them to bring life-saving drugs to market faster. The company will utilise 31% of the investment for commercialisation and marketing, 49% for product development, 13% for IT infrastructure, and 7% for administrative/legal/miscellaneous activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £532,311
WooHa brewing company started with a 3000 square foot and in 3 years moved to a 6.2 acre farm. WooHa is always focusing on export and US has always been their main target. They began exporting in 2016 and within a year had distribution in California, Washington DC and Tennessee. In the UK their beer can be found in supermarkets, bars and restaurants.

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £156,870
Creative Hub is a fast-growing cloud software platform for creative people to store, share files, and collaborate on projects. The collaboration tools also allow users to chat in real-time, and add comments on images, allowing creative teams to work faster and deliver better results. Creative Hub enables users to order professional art & photographic prints, or physical 3D prints, which are produced at its print production facilities in London(UK) and Dusseldorf (Germany). The platform currently has 40,000 active users which are growing day by day. With the investment, the company will drive growth through marketing and launch its New York production facility.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £286,992
Itasca Wines is a Hampshire-based vineyard and winery that produces fine English wines. The company is raising funds for its contract winemaking facility, to fulfil the growing demand from vineyards. There are over 760 vineyards in the UK currently, 111 have their own winery and only a handful of these provide contract winemaking services to other vineyards. Itasca Wines aims to become a major winemaker and create award-winning wines at Penn Croft. The company planted its first vineyard of 16,000 vines in May 2019 and has featured in Vineyard Magazine in February and May 2019.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,147,003
Algarve Rock Brewery manufactures Portuguese craft beer. The company aims to put Portuguese craft beer on the map with flavoursome beers that embody local ingredients. They have won Best Stout award in Trujillo Festival 2018- Spain. They supply to major Portuguese outlets including Emprodalbe distributors, Apolonia supermarkets, prestigious Quinta do Lago resort and 'house' beers to Casa do Frango group in London. The proceeds will be used to start its themed Brewbars and Brew kiosks, to increase exports to the UK and USA, strengthen brand identity, team expansion and expansion of brewery to cope with increased demand.

Pitch Rated

76%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £205,456
Rightangled is a DNA testing company backed by NHS that delivers services to consumers and medical/fitness specialists. The company is a full CQC healthcare provider license that has achieved registration with Bupa, a leading medical insurance company. The company is now planning to move into AI with a solid database. Rightangled has received excellent customer reviews with 5* on Google and 4.5* on Trustpilot. With the proceeds, the company will seek to launch its application, create a strong AI central system, and grow into new markets (US& UAE).

Pitch Rated

75%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £311,690
Skinny Tonic™ is the first Zero Calorie, Nothing Artificial, and Zero Sugar, 100 % Natural Tonic Water in the UK. It has a nationwide listing in Asda and a 2nd major listing agreed for 2020. Skinny Tonic™ also has been listed in major retailers including Amazon and Costco. The company has a bespoke, fully automated production facility capable of producing 6,000 cans per hour. With the proceeds, the company will recruit a marketing and sales team. Additionally, Skinny Tonic™ will increase its product development and production capacity.

Pitch Rated

75%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,783,994
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph